Earnings Feed
Start Free
NxStage Medical, Inc.·4

May 31, 9:03 PM ET

NxStage Medical, Inc. 4

4 · NxStage Medical, Inc. · Filed May 31, 2006

Insider Transaction Report

Form 4
Period: 2006-05-26
NxStage Medical, Inc.NXTM
ATLAS VENTURE FUND III L P
10% Owner
Transactions
  • Sale

    Common Stock

    2006-05-26$10.95/sh−6,795$74,405→ 691,068 total(indirect: See Footnote)
  • Exercise of In-Money

    Warrants to Purchase 10,434 Equity Securities

    2006-05-26−10,434→ 0 total
    Exercise: $7.13From: 2005-11-21Exp: 2006-05-31→ Common Stock (10,434 underlying)
  • Exercise of In-Money

    Common Stock

    2006-05-26$7.13/sh+10,434$74,394→ 691,068 total(indirect: See Footnote)
Footnotes (2)
  • [F1]See "Notes to Footnote 1" on Exhibit 99.2.
  • [F2]Following the reported transaction, Atlas Venture Fund III, L.P. holds 676,366 shares and Atlas Venture Enterpreneurs' Fund III, L.P. holds 14,702 shares of the Issure's common stock. The reporting persons disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.

Documents

3 files